Comparison of alternative approaches to trim subjects in the tails of the propensity score distribution.
Robert J GlynnMark LuntKenneth J RothmanCharles PooleSebastian SchneeweissTil StürmerPublished in: Pharmacoepidemiology and drug safety (2019)
Study populations with high PS C-statistics include only small percentages of subjects in whom valid treatment effects are confidently expected.
Keyphrases